Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions.
Musella A, Vertechy L, Romito A, Marchetti C, Giannini A, Sciuga V, Bracchi C, Tomao F, Di Donato V, De Felice F, Monti M, Muzii L, Benedetti Panici P. Musella A, et al. Among authors: tomao f. Chemotherapy. 2017;62(2):111-120. doi: 10.1159/000448942. Epub 2016 Oct 29. Chemotherapy. 2017. PMID: 27794568 Review.
Hemoglobin variation and blood transfusion rates in patients affected by locally advanced cervical cancer undergoing neo-adjuvant chemotherapy followed by radical surgery: the role of erythropoietic growth factors.
Bellati F, Pernice M, Manci N, Palaia I, Tomao F, Marchetti C, Zullo MA, Muzii L, Angioli R, Benedeth Panici P. Bellati F, et al. Among authors: tomao f. Ann Oncol. 2007 Apr;18(4):722-9. doi: 10.1093/annonc/mdl491. Epub 2007 Feb 16. Ann Oncol. 2007. PMID: 17307758 Free article.
Emerging role of pemetrexed in ovarian cancer.
Tomao F, Panici PB, Frati L, Tomao S. Tomao F, et al. Among authors: tomao s. Expert Rev Anticancer Ther. 2009 Dec;9(12):1727-35. doi: 10.1586/era.09.141. Expert Rev Anticancer Ther. 2009. PMID: 19954283 Review.
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.
Vici P, Fabi A, Metro G, Sergi D, Giannarelli D, Di Lauro L, Bepler G, Tomao F, Cognetti F, Conti F, Lopez M. Vici P, et al. Among authors: tomao f. Cancer Chemother Pharmacol. 2011 Mar;67(3):687-93. doi: 10.1007/s00280-010-1369-y. Epub 2010 May 29. Cancer Chemother Pharmacol. 2011. PMID: 20512334 Clinical Trial.
Epistaxis in weekly paclitaxel regimen: Is it really related to schedule?
Perniola G, Marchetti C, Caradio F, Tomao F, Benedetti Panici P. Perniola G, et al. Among authors: tomao f. Basic Clin Pharmacol Toxicol. 2011 Feb;108(2):77-8. doi: 10.1111/j.1742-7843.2010.00641.x. Epub 2010 Nov 12. Basic Clin Pharmacol Toxicol. 2011. PMID: 21073658 Free article. No abstract available.
Role of chemotherapy in the management of vulvar carcinoma.
Tomao F, Di Tucci C, Marchetti C, Perniola G, Bellati F, Panici PB. Tomao F, et al. Crit Rev Oncol Hematol. 2012 Apr;82(1):25-39. doi: 10.1016/j.critrevonc.2011.04.008. Epub 2011 May 20. Crit Rev Oncol Hematol. 2012. PMID: 21601474 Review.
Current knowledge and open issues regarding bevacizumab in gynaecological neoplasms.
Bellati F, Napoletano C, Gasparri ML, Ruscito I, Marchetti C, Pignata S, Tomao F, Benedetti Panici P, Nuti M. Bellati F, et al. Among authors: tomao f. Crit Rev Oncol Hematol. 2012 Jul;83(1):35-46. doi: 10.1016/j.critrevonc.2011.09.006. Epub 2011 Nov 4. Crit Rev Oncol Hematol. 2012. PMID: 22056314 Review.
172 results